Peter Ordentlich
8Patents
3h-index
10Co-inventors
54Inventor score
Filing activity: Mar 10, 2000 → May 7, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6673587B1 | Histone deacetylase, and uses therefor | Chemistry; Metallurgy | 13 | Expired |
| US10226472B2 | Methods for the treatment of breast cancer | Physics | 13 | Active |
| US11324822B2 | Combination of HDAC inhibitor and anti-PD-1 antibody for treatment of cancer | Chemistry; Metallurgy | 3 | Active |
| US11397184B2 | Selection of patients for combination therapy | Physics | 2 | Active |
| US8455489B2 | Substituted pyrimidine compositions and methods of use | Human Necessities | 0 | Active |
| US7314747B1 | SMRT co-repressors, transcriptional co-repressors that interact with nuclear hormone receptors | Physics | 0 | Expired |
| US12168054B2 | Method of treating cancer using a combination of entinostat and an anti-CSF-1R antibody | Chemistry; Metallurgy | 0 | Active |
| US12000829B2 | Selection of patients for combination therapy | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.